Governor Kremers Centre, Maastricht University, the Netherlands.
Université de Paris, NeuroDiderot, INSERM, Paris, France.
Sleep Med Rev. 2022 Jun;63:101614. doi: 10.1016/j.smrv.2022.101614. Epub 2022 Mar 3.
Despite the essential functions of melatonin in the human body, until now no norms of the amount of melatonin produced overnight have been established. Measuring the amount of the main urinary melatonin metabolite 6-sulfatoxymelatonin (aMT6s), corrected for creatinine, in the first morning void is the most simple as well as reliable method to evaluate the total amount of melatonin produced at night. We performed a meta-analysis to provide reference estimates and intervals by consolidating data from multiple studies. A total of 68 studies, representing 17,847 subjects, were retained for the analysis. No gender differences could be found in aMT6s values in this meta-review. aMT6s excretion is very high during the first 5 years of life, flattens out in adolescence with gradual decline continuing to 50-60 years, after which the decline stagnates and a limited increase occurs around about 60 years of age. This late increase may suggest the premature death of individuals with low aMT6s levels, as lower aMT6s levels are found in various disorders, such as cardiovascular diseases, cancer and neurodegenerative disorders. Our aMT6s values can be used to identify individuals with a possible melatonin deficiency.
尽管褪黑素在人体中具有重要的功能,但直到现在,还没有建立起一昼夜褪黑素产生量的标准。测量第一次晨尿中褪黑素主要代谢产物 6-硫酸褪黑素(aMT6s),并按肌酐校正,是评估夜间褪黑素总产生量最简便、最可靠的方法。我们进行了一项荟萃分析,通过合并多项研究的数据,提供参考估计值和范围。这项荟萃回顾共保留了 68 项研究,涉及 17847 名受试者。在这项荟萃分析中,没有发现 aMT6s 值存在性别差异。在生命的头 5 年,aMT6s 的排泄量非常高,在青春期趋于平稳,随着年龄的增长逐渐下降,持续到 50-60 岁,之后下降停滞,大约在 60 岁左右出现有限的增加。这种后期增加可能表明 aMT6s 水平较低的个体过早死亡,因为心血管疾病、癌症和神经退行性疾病等各种疾病中都发现了较低的 aMT6s 水平。我们的 aMT6s 值可用于识别可能存在褪黑素缺乏的个体。